Yesterday, European stocks were broadly higher. The Stoxx Europe 50 climbed 0.9%, Germany's DAX advanced 0.7%, France's CAC 40 rose 1.1%, and the U.K.'s FTSE 100 jumped 1.9%.
64% of STOXX 600 constituents traded higher yesterday.
71% of the shares trade above their 20D MA vs 70% Monday (below the 20D moving average).
85% of the shares trade above their 200D MA vs 84% Monday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 1.61pt to 21.3, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: Travel & Leisure, Basic Resource
3mths relative low: none
Europe Best 3 sectors
technology, utilities, energy
Europe worst 3 sectors
real estate, insurance, personal & household goods
The 10yr Bund yield rose 2bps to -0.57% (below its 20D MA). The 2yr-10yr yield spread fell 2bps to -19bps (below its 20D MA).
GE 08:00: Oct Retail Sales MoM, exp.: -2.2%
GE 08:00: Oct Retail Sales YoY, exp.: 6.5%
EC 09:00: ECB Non-Monetary Policy Meeting
UK 10:30: BoE FPC Meeting
EC 11:00: Oct Unemployment Rate, exp.: 8.3%
EC 11:00: Oct PPI MoM, exp.: 0.3%
EC 11:00: Oct PPI YoY, exp.: -2.4%
GE 11:40: 5-Year Bobl auction, exp.: -0.85%
EC 15:00: ECB Lane speech
In Asian trading hours, EUR/USD held gains at 1.2072 while GBP/USD eased to 1.3415. USD/JPY edged up to 104.42. AUD/USD slipped to 0.7373. Earlier today, official data showed that Australia's 3Q GDP fell 3.8% on year (-4.4% expected).
Spot gold retreated to $1,809 an ounce.
#UK - IRELAND#
Wizz Air, a low-cost airline, reported that passenger number declined 84.7% on year to 456,487 in November and the load factor dropped 24.5 percentage points to 68.2%.
Royal Dutch Shell, a giant oil producer, was upgraded to "overweight" from "neutral" at JPMorgan.
Volkswagen's, an automobile group, supervisory board will continue to meet in the coming days to discuss about CEO Herbert Diess's term and selections for top management posts, reported Bloomberg citing people familiar with the matter.
Allianz, a financial services group, has agreed to acquire Australian bank Westpac's general insurance business for 725 million Australian dollars, according to a statement from Westpac.
Hannover Re, a reinsurance group, was upgraded to "overweight" from "equalweight" at Morgan Stanley.
Total, a French oil giant, was downgraded to "neutral" from "overweight" at JPMorgan.
Repsol, a fossil fuel company, was downgraded to "underweight" from "neutral" at JPMorgan.
AB InBev, a multinational drink and brewing company, was downgraded to "neutral" from "buy" at Citigroup.
Source: TradingView, GAIN Capital
Roche, a multinational healthcare company, announced that the U.S. Food and Drug Administration has approved Gavreto (pralsetinib) for the treatment of advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers.
Hexagon: E0.62, Linde Plc (LIN): $0.963
GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.